Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TB-PRACTECAL: Short Regimens for MDR-TB
NCT02589782Phase 3Completed
- Sponsor
- Médecins Sans Frontières
- Start
- Jan 2017
- Primary completion
- Aug 2022
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of bedaquiline, pretomanid in pulmonary tuberculosis (TB), sponsored by Médecins Sans Frontières. Started Jan 2017; status: completed.
02
Drugs
bedaquilinepretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02589782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589782.